Aplidine is a potent antiviral agent against SARS-CoV-2 (IC90 = 0.88 nM) and an anti-cancer compound targeting EEF1A2 (Kd = 80 nM). Its applications span oncology and virology research, with studies demonstrating activity in both in vitro cellular assays and in vivo preclinical models.